Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Lowy

Showing results (251-260 of 401) with videos related to

Pageof 41
Sort By:
Microbiology Spectrum|May 16, 2023
Assay Harmonization Study To Measure Immune Response to SARS-CoV-2 Infection and Vaccines: a Serology Methods StudyTroy J Kemp, Heidi A Hempel, Yuanji Pan, et al.
Molecular and Cellular Biology|January 1, 1994
Neurofibromin can inhibit Ras-dependent growth by a mechanism independent of its GTPase-accelerating functionM R Johnson, J E DeClue, S Felzmann, et al.
The Journal of Cell Biology|December 3, 2014
CDK5 is a major regulator of the tumor suppressor DLC1Brajendra K Tripathi, Xiaolan Qian, Philipp Mertins, et al.
Journal of Virology|March 14, 2022
Chondroitin Sulfate Proteoglycans Are De Facto Cellular Receptors for Human Papillomavirus 16 under High Serum ConditionsNathan R Fons, Rhonda C Kines, Cynthia D Thompson, et al.
Molecular and Cellular Biology|December 1, 1991
The bovine papillomavirus E5 oncogene can cooperate with ras: identification of p21 amino acids critical for transformation by c-rasH but not v-rasHB M Willumsen, W C Vass, T J Velu, et al.
Human Vaccines & Immunotherapeutics|January 27, 2026
Development of HPV 35 serology assays for assessment of immune responses to HPV 35 after infection and vaccinationKathleen Kim, Carolina Porras, Aimee R Kreimer, et al.
Journal of Virology|December 1, 1993
Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particlesR Kirnbauer, J Taub, H Greenstone, et al.
Journal of the National Cancer Institute|August 7, 2003
Specific antibody levels at the cervix during the menstrual cycle of women vaccinated with human papillomavirus 16 virus-like particlesDenise Nardelli-Haefliger, Daniel Wirthner, John T Schiller, et al.
Journal of Virology|December 17, 2008
Role of heparan sulfate in attachment to and infection of the murine female genital tract by human papillomavirusKatherine M Johnson, Rhonda C Kines, Jeffrey N Roberts, et al.
Journal of Neurodevelopmental Disorders|March 17, 2016
Reduced engagement with social stimuli in 6-month-old infants with later autism spectrum disorder: a longitudinal prospective study of infants at high familial riskE J H Jones, K Venema, R Earl, et al.
Pageof 41

Showing results (251-260 of 401) with videos related to

Sort By:
Pageof 41
Microbiology Spectrum|May 16, 2023
Assay Harmonization Study To Measure Immune Response to SARS-CoV-2 Infection and Vaccines: a Serology Methods StudyTroy J Kemp, Heidi A Hempel, Yuanji Pan, et al.
Molecular and Cellular Biology|January 1, 1994
Neurofibromin can inhibit Ras-dependent growth by a mechanism independent of its GTPase-accelerating functionM R Johnson, J E DeClue, S Felzmann, et al.
The Journal of Cell Biology|December 3, 2014
CDK5 is a major regulator of the tumor suppressor DLC1Brajendra K Tripathi, Xiaolan Qian, Philipp Mertins, et al.
Journal of Virology|March 14, 2022
Chondroitin Sulfate Proteoglycans Are De Facto Cellular Receptors for Human Papillomavirus 16 under High Serum ConditionsNathan R Fons, Rhonda C Kines, Cynthia D Thompson, et al.
Molecular and Cellular Biology|December 1, 1991
The bovine papillomavirus E5 oncogene can cooperate with ras: identification of p21 amino acids critical for transformation by c-rasH but not v-rasHB M Willumsen, W C Vass, T J Velu, et al.
Human Vaccines & Immunotherapeutics|January 27, 2026
Development of HPV 35 serology assays for assessment of immune responses to HPV 35 after infection and vaccinationKathleen Kim, Carolina Porras, Aimee R Kreimer, et al.
Journal of Virology|December 1, 1993
Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particlesR Kirnbauer, J Taub, H Greenstone, et al.
Journal of the National Cancer Institute|August 7, 2003
Specific antibody levels at the cervix during the menstrual cycle of women vaccinated with human papillomavirus 16 virus-like particlesDenise Nardelli-Haefliger, Daniel Wirthner, John T Schiller, et al.
Journal of Virology|December 17, 2008
Role of heparan sulfate in attachment to and infection of the murine female genital tract by human papillomavirusKatherine M Johnson, Rhonda C Kines, Jeffrey N Roberts, et al.
Journal of Neurodevelopmental Disorders|March 17, 2016
Reduced engagement with social stimuli in 6-month-old infants with later autism spectrum disorder: a longitudinal prospective study of infants at high familial riskE J H Jones, K Venema, R Earl, et al.
Pageof 41